France will administer the 200,000 doses of the Johnson & Johnson vaccine it has received, according to the French government spokesperson Wednesday.
“200,000 doses arrived at the beginning of the week and they are being sent to doctors and pharmacies,” Gabriel Attal said during a news conference.
“It will be administered to people over the age of 55, the same way AstraZeneca is," he added.
On Tuesday, Johnson & Johnson unilaterally announced that it was pausing deliveries of its single-dose vaccines to the EU, which were scheduled to start this week, following cases of “an extremely rare disorder involving people with blood clots in combination with low platelets in a small number of individuals.”
The US CDC and FDA recommended yesterday a pause of the vaccine over blood clot concerns "out of an abundance of caution." Six reported blood clot cases were among more than 6.8 million doses of the vaccine administered in the US.
Attal also expressed confidence in the AstraZeneca vaccine.
“There are indeed cases of blood clots that have been detected but they are extremely rare and are infinitely less important than the protection provided by this vaccine,” Attal said.
“I reiterate our choice to continue vaccinating with AstraZeneca, which is one of the essential elements in our vaccination campaign”.